Admission Hyperglycemia and TIMI Frame Count in Primary Percutaneous Coronary Intervention
ANGIOLOGY, cilt.63, sa.5, ss.325-329, 2012 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 63 Sayı: 5
- Basım Tarihi: 2012
- Doi Numarası: 10.1177/0003319711418957
- Dergi Adı: ANGIOLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.325-329
- Anahtar Kelimeler: coronary flow, blood glucose, ST-segment elevation myocardial infarction, ACUTE MYOCARDIAL-INFARCTION, DIABETES-MELLITUS, ARTERY-DISEASE, GLUCOSE, PREVALENCE, MORTALITY, FLOW
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet
Özet
We evaluated the relationship between admission blood glucose levels and estimated coronary flow by the thrombolysis in myocardial infarction (TIMI) frame count (TFC) method in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI). The TFC of 121 consecutive patients with STEMI were evaluated after pPCI. Patients with admission glucose levels > 198 mg/dL (11 mmol/L) were defined as hyperglycemic. Hyperglycemia was observed in 36 (29.8%) patients. The TFC was significantly higher in patients with hyperglycemia (70.75 [10-96] vs 56.87 [8-100], P = .04). No-reflow frequency was higher in the hyperglycemia group (44.4% vs 23.5%, P = .02). In multivariate linear regression analysis admission glucose was an independent predictor of high TFC (B = 0.21, P = .02). Our findings suggest that admission blood glucose is a predictor of TFC which reflects coronary blood flow.